Effects of root extracts of Fagara zanthoxyloides on the in vitro growth and stage distribution of Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 1, 2005, Pages 264-268

  Kassim, Olakunle O ^a   Loyevsky, Mark ^a   Elliott, Biaffra ^a   Geall, Andrew ^b   Amonoo, Henrietta ^a   Gordeuk, Victor R ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Biocal Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAGARA ZANTHOXYLOIDES EXTRACT; FAGARONINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FAGARA ZANTHOXYLOIDES; GIEMSA STAIN; GROWTH INHIBITION; IC 50; MALARIA CONTROL; NONHUMAN; PLANT ROOT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCHIZONT; TROPHOZOITE;

ALKALOIDS; ANIMALS; ANTIMALARIALS; HUMANS; LIFE CYCLE STAGES; PARASITIC SENSITIVITY TESTS; PHENANTHRIDINES; PLANT EXTRACTS; PLANT ROOTS; PLASMODIUM FALCIPARUM; RUTACEAE;

EID: 11244341554     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.1.264-268.2005     Document Type: Article

References (25)

1. Addae-Kyereme, J., S. L. Croft, H. Kendrick, and C. W. Wright. 2001. Antiplasmodial activities of some Ghanaian plants traditionally used for fever/malaria treatment and of some alkaloids isolated from Pleiocarpa mutica; in vivo antimalarial activity of pleiocarpine. J. Ethnopharmacol. 76:99-103.
2. Agbedahunsi, J. M. 2000. Screening of crude drugs for the treatment of malaria in Nigeria, p. 4-8. In C. O. Adewunmi and S. K. Adesina (ed.), Phytomedicines in malaria and sexually transmitted diseases: challenges for the new millennium. Obafemi Awolowo University, Ile-Ife, Nigeria.
3. Ajaiyeoba, E. O., U. I. Abalogu, H. C. Krebs, and A. M. J. Oduola. 1999. In vivo antimalarial activities of Quassia amara and Quassia undulate plant extracts in mice. J. Ethnopharm. 67:321-325.
4. Birku, Y., E. Makonnen, and A. Bjorkman. 1999. Comparison of rectal artemisinin with intravenous quinine in the treatment of severe malaria in Ethiopia. East Afr. Med. J. 76:154-159.
5. Breman, J. G. 2001. The ears of the hippopotamus: manifestations, determinants and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 64(Suppl. 1):1-11.
6. Carme, B., J. C. Bouguenty, and H. Plassart. 1993. Mortality and sequelae due to cerebral malaria in African children in Brazaville, Congo. Am. J. Trop. Med. Hyg. 48:216-221.
7. Guyatt, H. L., and R. W. Snow. 2001. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am. J. Trop. Med. Hyg. 64(Suppl. 1):36-44.
8. Larsen, A. K., L. Grondard, J. Couprie, B. Desoize, L. Comor, J. C. Jardillier, and J. F. Riou. 1993. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochem. Pharmacol. 46:1403-1412.
9. Loyevsky, M., S. Lytton, B. Mester, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1993. The antimalarial action of desferal involves direct access route to erythrocytic (Plasmodium falciparum) parasites. J. Clin. Investig. 91:218-224.
10. Masaba, S. C. 2000. The antimalarial activity of Vernonia amygdalina Del (Compositae). Trans. R. Soc. Trop. Med. Hyg. 94:694-695.
11. McGready, R., A. Brockman, T. Cho, D. Cho, M. van Vugt, C. Luxemburger, T. Chongsuphajaisiddhi, N. J. White, and F. Nosten. 2000. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 94:689-693.
12. Messmer, W. M., M. Tin-Wa, H. H. S. Fong, C. Bevelle, N. R. Farnsworth, D. J. Abraham, and J. Trojanek. 1972. Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides Lam. (Rutaceae). J. Pharm. Sci. 61:1858-1859.
13. Murphy, S. C., and J. G. Breman. 2001. Gaps in the childhood malaria burden in Africa: adding cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia and complications of pregnancy to the calculus. Am. J. Trop. Med. Hyg. 64(Suppl. 1):57-67.
14. Odebiyi, O. O., and E. S. Sofowora. 1979. Antimicrobial alkaloids from a Nigerian chewing stick (Fagara zanthoxyloides). Planta Med. 36:204-207.
15. Ogwal-Okeng, J. W., C. Obua, and W. W. Anokbonggo. 2003. Acute toxicity effects of the methanolic extract of Fagara zanthoxyloides (Lam.) root-bark. Aft. Health Sci. 3:124-126.
16. Prado, S., S. Michel, F. Tillequin, M. Koch, B. Pffeiffer, A. Pierre, S. Leonce, P. Colson, B. Baldeyrou, A. Lansiaux, and C. Bailly. 2004. Synthesis and cytotoxic activity of benzo[c][1,7] and [1,8]phenanthrolines analogues of nitidine and fagaronine. Bioorg. Med. Chem. 12:3943-3953.
17. Skinner, T. S., L. S. Manning, W. A. Johnston, and T. M. Davis. 1996. In vitro stage-specific sensitivity of Plasmosium falciparum to quinine and artemisinin drugs. Int. J. Parasitol. 26:519-525.
18. Sofowora, E. A., and W. A. Isaacs. 1971. Reversal of sickling and crenation in erythrocytes by the root extract of Fagara zanthoxyloides. Lloydia 34:383-385.
19. Steketee, R. W., B. L. Nahlen, M. E. Parise, and C. Menendez. 2001. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg. 64(Suppl. 1):28-35.
20. Takanishi, T., M. Suzuki, A. Saiomoto, and T. Kabasawa. 1999. Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid. J. Nat. Prod. (Lloydia) 62:864-867.
21. Trager, W., and J. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
22. Udeinya, I. J. 1993. Anti-malaria activity of Nigerian neem leaves. Trans. R. Soc. Trop. Med. Hyg. 87:471.
23. Ulrichova, J., Z. Dvorak, J. Vicar, J. Lata, J. Smrzova, A. Sedo, and V. Simanek. 2001. Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthridine alkaloids. Toxicol. Lett. 125:125-132.
24. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.
25. World Health Organization. 1997. World malaria situation in 1994. Part I. Population at risk. Wkly. Epidemiol. Rec. 72:269-274.